论文部分内容阅读
In this lecture, we shall present our recent study focusing on a compound transdermal patch containing Teriflunomide(TEF) and lornoxicam (LOX), which is designed to control the skin permeation rate of TEF and LOX by utilizing ion pair technology to a similar extend for therelief of RA symptoms.